Terms: = Kidney tumors AND KMT2D, ENSG00000167548, 8085, MLL2
41 results:
1. Comparison and validation of different risk models for papillary renal cell carcinoma.
Lin H; Sun Q; Li Z; Zheng J; Zhang X; Xiong Y; Chen H; Hou Y; Xi W; Lin J
Urol Oncol; 2023 Aug; 41(8):358.e1-358.e7. PubMed ID: 37394414
[TBL] [Abstract] [Full Text] [Related]
2. kmt2d links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity.
Lu S; Kim HS; Cao Y; Bedi K; Zhao L; Narayanan IV; Magnuson B; Gu Y; Yang J; Yi Z; Babaniamansour S; Shameon S; Xu C; Paulsen MT; Qiu P; Jeyarajan S; Ljungman M; Thomas D; Dou Y; Crawford H; di Magliano MP; Ge K; Yang B; Shi J
Int J Cancer; 2023 Aug; 153(3):552-570. PubMed ID: 37140208
[TBL] [Abstract] [Full Text] [Related]
3. A novel dataset and efficient deep learning framework for automated grading of renal cell carcinoma from kidney histopathology images.
Chanchal AK; Lal S; Kumar R; Kwak JT; Kini J
Sci Rep; 2023 Apr; 13(1):5728. PubMed ID: 37029115
[TBL] [Abstract] [Full Text] [Related]
4. Histone methyltransferase kmt2d promotes prostate cancer progression through paracrine IL-6 signaling.
Zhang J; Ye Y; Xu Z; Luo M; Wu C; Zhang Y; Lv S; Wei Q
Biochem Biophys Res Commun; 2023 May; 655():35-43. PubMed ID: 36924677
[TBL] [Abstract] [Full Text] [Related]
5. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
6. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
[TBL] [Abstract] [Full Text] [Related]
7. Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma.
Tripathi N; Jo Y; Tripathi A; Sayegh N; Li H; Nussenzveig R; Haaland B; Thomas VM; Gupta S; Maughan BL; Swami U; Pal SK; Grivas P; Agarwal N; Sirohi D
Urol Oncol; 2022 Nov; 40(11):493.e1-493.e7. PubMed ID: 35918248
[TBL] [Abstract] [Full Text] [Related]
8. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
Murugan P; Jia L; Dinatale RG; Assel M; Benfante N; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Hakimi AA; Russo P; Chen YB; Tickoo SK; Reuter VE
Mod Pathol; 2022 Jun; 35(6):825-835. PubMed ID: 34949764
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Analysis of Large-Scale Transcriptomes from Multiple Cancer Types.
Nong B; Guo M; Wang W; Songyang Z; Xiong Y
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946814
[TBL] [Abstract] [Full Text] [Related]
10. Management of Very Late Pancreatic Metastasis of Renal Cell Carcinoma 8 Years After Radical Nephrectomy: A Report of a Rare Case.
Alayyaf N; AlQatari AA; Altalib A; AlQattan AS; Alshahrani AA
Am J Case Rep; 2021 Jan; 22():e927921. PubMed ID: 33400693
[TBL] [Abstract] [Full Text] [Related]
11. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer.
Tran N; Broun A; Ge K
Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139
[TBL] [Abstract] [Full Text] [Related]
12. NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations.
Kao YC; Sung YS; Argani P; Swanson D; Alaggio R; Tap W; Wexler L; Dickson BC; Antonescu CR
Mod Pathol; 2020 Jul; 33(7):1341-1349. PubMed ID: 32034283
[TBL] [Abstract] [Full Text] [Related]
13. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetic modifiers: activities in renal cell carcinoma.
de Cubas AA; Rathmell WK
Nat Rev Urol; 2018 Oct; 15(10):599-614. PubMed ID: 30030490
[TBL] [Abstract] [Full Text] [Related]
15. Cancer Management in Kabuki Syndrome: The First Case of Wilms Tumor and a Literature Review.
Teranishi H; Koga Y; Nakashima K; Morihana E; Ishii K; Sakai Y; Taguchi T; Oda Y; Miyake N; Matsumoto N; Ohga S
J Pediatr Hematol Oncol; 2018 Jul; 40(5):391-394. PubMed ID: 29489735
[TBL] [Abstract] [Full Text] [Related]
16. Changing the Stage, Grade and Histological Subtypes of Renal Cell Carcinomas during 10 Years Period.
Çalışkan S; Koca O; Akyüz M; Öztürk Mİ; Karaman MI
Prague Med Rep; 2017; 118(4):119-127. PubMed ID: 29324219
[TBL] [Abstract] [Full Text] [Related]
17. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
[TBL] [Abstract] [Full Text] [Related]
18. Histone H3 lysine 4 methyltransferase kmt2d.
Froimchuk E; Jang Y; Ge K
Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.
Moss TJ; Qi Y; Xi L; Peng B; Kim TB; Ezzedine NE; Mosqueda ME; Guo CC; Czerniak BA; Ittmann M; Wheeler DA; Lerner SP; Matin SF
Eur Urol; 2017 Oct; 72(4):641-649. PubMed ID: 28601352
[TBL] [Abstract] [Full Text] [Related]
20. Systematic discovery of complex insertions and deletions in human cancers.
Ye K; Wang J; Jayasinghe R; Lameijer EW; McMichael JF; Ning J; McLellan MD; Xie M; Cao S; Yellapantula V; Huang KL; Scott A; Foltz S; Niu B; Johnson KJ; Moed M; Slagboom PE; Chen F; Wendl MC; Ding L
Nat Med; 2016 Jan; 22(1):97-104. PubMed ID: 26657142
[TBL] [Abstract] [Full Text] [Related]
[Next]
